1. Home
  2. FOXX vs MRKR Comparison

FOXX vs MRKR Comparison

Compare FOXX & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$2.00

Market Cap

17.3M

Sector

N/A

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

19.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOXX
MRKR
Founded
2017
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
19.5M
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
FOXX
MRKR
Price
$2.00
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
5.9K
★ 162.3K
Earning Date
11-17-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.61
EPS
N/A
★ N/A
Revenue
★ $52,584,432.00
N/A
Revenue This Year
N/A
$19.61
Revenue Next Year
N/A
$375.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.71
$0.84
52 Week High
$7.90
$2.46

Technical Indicators

Market Signals
Indicator
FOXX
MRKR
Relative Strength Index (RSI) 34.71 43.06
Support Level N/A $0.88
Resistance Level $2.77 $1.34
Average True Range (ATR) 0.21 0.10
MACD -0.04 0.01
Stochastic Oscillator 10.64 26.97

Price Performance

Historical Comparison
FOXX
MRKR

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: